GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (NAS:RDNT) » Definitions » Cyclically Adjusted PS Ratio

RDNT (RadNet) Cyclically Adjusted PS Ratio : 2.18 (As of May. 31, 2025)


View and export this data going back to 1994. Start your Free Trial

What is RadNet Cyclically Adjusted PS Ratio?

As of today (2025-05-31), RadNet's current share price is $57.51. RadNet's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $26.33. RadNet's Cyclically Adjusted PS Ratio for today is 2.18.

The historical rank and industry rank for RadNet's Cyclically Adjusted PS Ratio or its related term are showing as below:

RDNT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.31   Med: 0.81   Max: 3.18
Current: 2.18

During the past years, RadNet's highest Cyclically Adjusted PS Ratio was 3.18. The lowest was 0.31. And the median was 0.81.

RDNT's Cyclically Adjusted PS Ratio is ranked worse than
51.52% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.07 vs RDNT: 2.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

RadNet's adjusted revenue per share data for the three months ended in Mar. 2025 was $6.338. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $26.33 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


RadNet Cyclically Adjusted PS Ratio Historical Data

The historical data trend for RadNet's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet Cyclically Adjusted PS Ratio Chart

RadNet Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 1.36 0.79 1.40 2.69

RadNet Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 2.30 2.69 2.69 1.89

Competitive Comparison of RadNet's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, RadNet's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RadNet's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RadNet's Cyclically Adjusted PS Ratio falls into.


;
;

RadNet Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

RadNet's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=57.51/26.33
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RadNet's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, RadNet's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.338/134.9266*134.9266
=6.338

Current CPI (Mar. 2025) = 134.9266.

RadNet Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 4.572 100.684 6.127
201509 4.656 100.392 6.258
201512 4.632 99.792 6.263
201603 4.645 100.470 6.238
201606 4.662 101.688 6.186
201609 4.848 101.861 6.422
201612 4.851 101.863 6.426
201703 4.919 102.862 6.452
201706 4.874 103.349 6.363
201709 4.784 104.136 6.199
201712 4.919 104.011 6.381
201803 4.839 105.290 6.201
201806 5.036 106.317 6.391
201809 4.981 106.507 6.310
201812 5.220 105.998 6.645
201903 5.480 107.251 6.894
201906 5.765 108.070 7.198
201909 5.812 108.329 7.239
201912 5.941 108.420 7.393
202003 5.598 108.902 6.936
202006 3.761 108.767 4.666
202009 5.616 109.815 6.900
202012 5.999 109.897 7.365
202103 5.969 111.754 7.207
202106 6.285 114.631 7.398
202109 6.182 115.734 7.207
202112 6.177 117.630 7.085
202203 6.064 121.301 6.745
202206 6.221 125.017 6.714
202209 6.072 125.227 6.542
202212 6.599 125.222 7.110
202303 6.769 127.348 7.172
202306 6.627 128.729 6.946
202309 5.842 129.860 6.070
202312 6.095 129.419 6.354
202403 6.229 131.776 6.378
202406 6.262 132.554 6.374
202409 6.135 133.029 6.223
202412 5.869 133.157 5.947
202503 6.338 134.927 6.338

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RadNet  (NAS:RDNT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


RadNet Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of RadNet's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RadNet Business Description

Traded in Other Exchanges
Address
1510 Cotner Avenue, Los Angeles, CA, USA, 90025
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Executives
Gregory Sorensen director, officer: EVP Chief Science Officer C/O DFB HEALTHCARE ACQUISITIONS CORP, 780 THIRD AVENUE, NEW YORK NY 10017
Stephen M Forthuber officer: Executive Vice President 3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 75201-2776
Lawrence L Levitt director 2934 1/2 BEVERLY GLEN CIRCLE #325, LOS ANGELES CA 90077
Norman R Hames director, officer: Vice President
David L Swartz director 1510 COTNER AVENUE, LOS ANGELES CA 90025
David Jeffrey Katz officer: EVP and General Counsel 1510 COTNER AVE, LOS ANGELES CA 90025
Ranjan Jayanathan officer: Chief Information Officer 13388 HUNT RIDGE ROAD, ELLICOTT CITY MD 21042
Michael N Murdock officer: Executive Vice President 3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 752012776
Mital Patel officer: Executive Vice President 1510 COTNER AVENUE, LOS ANGELES CA 90025
Gregory E. Spurlock director 4116 E. NORTHRIDGE CIRCLE, MESA AZ 85215-9807
Mark Stolper director 150 COTNER AVENUE, LOS ANGELES CA 90025
Christine Nayoma Gordon director 3081 PANAMA AVE., CARMICHAEL CA 95608
Ruth Louisa Villigerwilson director, officer: Senior Vice President 3700 WALNUT AVENUE, LONG BEACH CA 90801
John V Crues director 1510 COTNER AVE, LOS ANGELES CA 90025
Laura Pastre Jacobs director 10154 BRIDLEVALE DRIVE, LOS ANGELES CA 90064